Sino Biopharmaceutical Limited (HKG:1177) saw its stock price soar by 5.07% during Friday's intraday trading session, catching investors' attention amidst a significant insider purchase.

The surge in stock price comes on the heels of a substantial insider transaction. Ping Tse, the Founder and Senior Executive Vice Chairman of Sino Biopharmaceutical, invested a whopping HK$222 million to acquire company shares at an average price of HK$7.44. This purchase, while only increasing Tse's holding by 1.8%, represents a strong vote of confidence in the company's future prospects.

Insider buying often signals management's belief in the company's value and potential for growth. This substantial investment by a key executive could be interpreted as a positive indicator for Sino Biopharm's outlook. The company already boasts high insider ownership at 51%, suggesting strong alignment between management and shareholder interests. As the market digests this information, investors appear to be responding favorably, driving up the stock price in today's trading session.